HAGAR Unveils New Clinical Data on Groundbreaking GWave Technology, Closing Round C Funding

TEL AVIV, Israel, August 10, 2023--HAGAR, the developer of GWave, a non-invasive continuous glucose monitoring technology that uses RF (radio frequency) waves to measure glucose levels in the blood, has announced it closed a Round C funding round of $5 million, bringing its total raised to date to $25 million. Additionally, Dr. Irl Hirsch presented HAGAR’s latest data from a proprietary study conducted at the Weizmann Institute of Science on the GWave device at the 83rd Scientific Sessions of th

Related Keywords

New York ,United States ,Israel ,American ,James Hirsch ,Roy Beck ,Jaeb Center ,Health Research ,Weizmann Institute Of Science ,Drug Administration ,Gwave Shined At American Diabetes Association ,Scientific Sessions Of The American Diabetes Association ,American Diabetes Association ,Latest Clinical ,Irl Hirsch ,Weizmann Institute ,Scientific Sessions ,Ami Navon ,Typei Diabetes ,Clarke Error Grid ,New York Times ,Wall Street Journal ,Breakthrough Device Designation ,Glucose Levels ,Wave ,Agar ,R Hirsch ,Continuous Glucose Monitoring ,